|
1
|
Wallace DV: Treatment options for chronic
rhinosinusitis with nasal polyps. Allergy Asthma Proc. 42:450–460.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Snidvongs K, Sangubol M and Poachanukoon
O: Pediatric versus adult chronic rhinosinusitis. Curr Allergy
Asthma Rep. 20(29)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ramadan HH: Pediatric chronic
rhinosinusitis. Eur Arch Otorhinolaryngol. 281:1131–1137.
2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Poachanukoon O, Nanthapisal S and
Chaumrattanakul U: Pediatric acute and chronic rhinosinusitis:
Comparison of clinical characteristics and outcome of treatment.
Asian Pac J Allergy Immunol. 30:146–151. 2012.PubMed/NCBI
|
|
5
|
Siddiqui Z, Tahiri M, Gupta A, Kin Nam RH
and Rachmanidou A: The management of paediatric rhinosinusitis. Int
J Pediatr Otorhinolaryngol. 147(110786)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ventriglia G, Gervasoni F, Franco M, Magni
A, Panico G and Iolascon G: Musculoskeletal pain management and
thermotherapy: An exploratory analysis of italian physicians'
attitude, beliefs, and prescribing habits. J Pain Res.
16:1547–1557. 2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yang X, Li K, Li M, Chen C, Yang X, Li J
and Zhang H: Ultrashort wave diathermy inhibits pulmonary
inflammation in mice with acute lung injury in a HSP70 independent
way: A pilot study. Mol Biol Rep. 51(750)2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yu HPM, Jones AY, Dean E and Liisa Laakso
E: Ultra-shortwave diathermy-a new purported treatment for
management of patients with COVID-19. Physiother Theory Pract.
36:559–563. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kong L, Zhang JL and Zhu CM: Ultrashort
wave therapy for chronic rhinosinusitis with nasal polyps: protocol
for a randomized, double-blind, sham-controlled trial. Trials.
26(391)2025.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fouda KZ, Eladl HM, Ameer MA and Allam NM:
Effect of adding physiotherapy program to the conservative medical
therapy on quality of life and pain in chronic rhinosinusitis
patients. Ann Rehabil Med. 47:393–402. 2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals, 8th
edition. National Academies Press (US), Washington, DC, 2011.
|
|
12
|
Geng L, Wang S, Zhao Y and Hu H: Gene
expression profile in mouse bacterial chronic rhinosinusitis. Exp
Ther Med. 17:3451–3458. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yu H, Huang X, Xie C, Song J, Zhou Y, Shi
H, Chen M, Wu Y, Ruan Z, Deng L, et al: Transcriptomics reveals
apigenin alleviates airway inflammation and epithelial cell
apoptosis in allergic asthma via MAPK pathway. Phytother Res.
37:4002–4017. 2023.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Makary CA, Tumlin P, Asad F, Wasef K and
Ramadan HH: Quality of life measurement for adolescent patients
with sinonasal symptoms. Laryngoscope. 133:1052–1058.
2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Levy DA, Pecha PP, Nguyen SA and Schlosser
RJ: Trends in complications of pediatric rhinosinusitis in the
United States from 2006 to 2016. Int J Pediatr Otorhinolaryngol.
128(109695)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mirza AA, Shawli HY, Alandejani TA,
Aljuaid SM, Alreefi M, Basonbul RA, Alhomaiani SK, Althobaity BA,
Alhumaidi DA and Zawawi F: Efficacy and safety of paranasal sinus
balloon catheter dilation in pediatric chronic rhinosinusitis: A
systematic review. J Otolaryngol Head Neck Surg.
49(69)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ma X, Guo S, Liu F, Li C, Shi X, Liu W, Qi
L, Yuan Y, Xie X, Wang P, et al: Unveiling the prevalence and
impact of silent rhinovirus infection in chronic rhinosinusitis
with nasal polyps. Ann Allergy Asthma Immunol. 134:420–430.e1.
2025.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Song J, Wang M, Wang C and Zhang L:
Olfactory dysfunction in chronic rhinosinusitis: Insights into the
underlying mechanisms and treatments. Expert Rev Clin Immunol.
19:993–1004. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ruysseveldt E, Martens K and Steelant B:
Airway basal cells, protectors of epithelial walls in health and
respiratory diseases. Front Allergy. 2(787128)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Alekseenko S, Karpischenko S and
Barashkova S: Comparative analysis of mucociliary clearance and
mucosal morphology using high-speed videomicroscopy in children
with acute and chronic rhinosinusitis. Am J Rhinol Allergy.
35:656–663. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chegini Z, Noei M, Hemmati J, Arabestani
MR and Shariati A: The destruction of mucosal barriers, epithelial
remodeling, and impaired mucociliary clearance: Possible pathogenic
mechanisms of Pseudomonas aeruginosa and Staphylococcus aureus in
chronic rhinosinusitis. Cell Commun Signal. 21(306)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang C, Yan B and Zhang L: The
epithelium-derived inflammatory mediators of chronic rhinosinusitis
with nasal polyps. Expert Rev Clin Immunol. 16:293–310.
2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mitoma H, Horiuchi T, Tsukamoto H and Ueda
N: Molecular mechanisms of action of anti-TNF-α agents-comparison
among therapeutic TNF-α antagonists. Cytokine. 101:56–63.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chufistova AV, Shabaldina EV, Bedareva AV,
Vakhrameev IN, Abramova NA and Shabaldin AV: Features of
inflammatory endotypes and phenotypes in chronic rhinosinusitis.
Vestn Otorinolaringol. 89:60–67. 2024.PubMed/NCBI View Article : Google Scholar : (In Russian).
|
|
25
|
Xuan L, Zhang N, Wang X, Zhang L and
Bachert C: IL-10 family cytokines in chronic rhinosinusitis with
nasal polyps: From experiments to the clinic. Front Immunol.
13(947983)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liang Y, Yin S, Chen X, Li C and Chen Q:
The causal relationship between autoimmune diseases and
rhinosinusitis, and the mediating role of inflammatory proteins: A
Mendelian randomization study. Exp Biol Med (Maywood).
249(10196)2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yue Q, Liu T and Cheng Z: Protective
effect of colchicine on LPS-induced lung injury in rats via
inhibition of P-38, ERK1/2, and JNK activation. Pharmacology.
105:639–644. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jang EJ, Kim H, Baek SE, Jeon EY, Kim JW,
Kim JY and Kim CD: HMGB1 increases RAGE expression in vascular
smooth muscle cells via ERK and p-38 MAPK-dependent pathways.
Korean J Physiol Pharmacol. 26:389–396. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fawzy MA, Maher SA, Bakkar SM, El-Rehany
MA and Fathy M: Pantoprazole attenuates MAPK (ERK1/2, JNK,
p38)-NF-κB and apoptosis signaling pathways after renal
ischemia/reperfusion injury in rats. Int J Mol Sci.
22(10669)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lee M, Kim DW, Khalmuratova R, Shin SH,
Kim YM, Han DH, Kim HJ, Kim DY, Rhee CS, Park JW and Shin HW: The
IFN-γ-p38, ERK kinase axis exacerbates neutrophilic chronic
rhinosinusitis by inducing the epithelial-to-mesenchymal
transition. Mucosal Immunol. 12:601–611. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Victores AJ, Chen MF, Smith A and Lane AP:
Olfactory loss in chronic rhinosinusitis is associated with
neuronal activation of c-Jun N-terminal kinase. Int Forum Allergy
Rhinol. 8:415–420. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wu YS, Sun KY, Tu YY, Li P, Hao D, Yu P,
Chen A, Wan Y and Shi L: miR-200a-3p regulates
epithelial-mesenchymal transition and inflammation in chronic
rhinosinusitis with nasal polyps by targeting ZEB1 via ERK/p38
pathway. Int Forum Allergy Rhinol. 14:41–56. 2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen W, Liu ZJ and Ye J: Relationship
among the expression of GSK3β, PI3K/Akt, and IL-6 in chronic
rhinosinusitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
48:128–134. 2013.PubMed/NCBI(In Chinese).
|
|
34
|
Yang HW, Kim HJ, Park JH, Shin JM and Lee
HM: Apigenin alleviates TGF-β1-induced nasal mucosa remodeling by
inhibiting MAPK/NF-kB signaling pathways in chronic rhinosinusitis.
PLoS One. 13(e0201595)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chen XH, Chang LH, Li X, Huang J, Yang L,
Lai X, Huang Z, Wang Z, Wu X, Zhao J, et al: Tc17/IL-17A
Up-regulated the expression of MMP-9 via NF-κB pathway in nasal
epithelial cells of patients with chronic rhinosinusitis. Front
Immunol. 19(2121)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang S, Jia Y, Cao X, Feng S, Na L, Dong
H, Gao J and Zhang L: HUCMSCs transplantation combined with
ultrashort wave therapy attenuates neuroinflammation in spinal cord
injury through NUR77/NF-κB pathway. Life Sci.
267(118958)2021.PubMed/NCBI View Article : Google Scholar
|
